We observed a trend toward an increase in the percentage of IL-6+ monocytes and a decrease in the percentage of CD4+IFN-γ+ and CD8+IFN-γ+ lymphocytes in COVID-19 patients, indicating that mononuclear cells support a high concentration of IL-6 and a low response to IFN-γ. The gene discussed is IL6; the disease is COVID-19.